Other recent experiments on prostate cancer cells revealed that the secretion of exosomes by prostate cancer cells and their bioactive content, such as vascular endothelial growth factor, depends critically on the availability of plasma-complexed lipids [18], and multiple studies have addressed the reflection of specific available lipids on the exosomes’ biogenesis pathways, which lead to differentiated bioactive content, for example, the exosome-bound microRNA (miRNA) [25,26]. The gene discussed is VEGFA; the disease is prostate cancer.